INBIOGEN CO., Ltd. (101140) Price & Analysis

― Followers

101140 Stock Chart & Stats

₩5200.00

₩30.00(0.58%)

Jul 24, 2026

―

Day’s Range― - ―

52-Week Range₩4,805.00 - ₩14,300.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)5.86K

Market Cap

₩51.92B

Enterprise ValueN/A

Total Cash (Recent Filing)₩3.53B

Total Debt (Recent Filing)₩4.11B

Price to Earnings (P/E)―

Beta0.27

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1093.26

Shares Outstanding10,044,217

10 Day Avg. Volume3,759

30 Day Avg. Volume5,857

Financial Highlights & Ratios

PEG Ratio-0.28

Price to Book (P/B)0.67

Price to Sales (P/S)16.73

P/FCF Ratio-18.83

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

101140 FAQ

What was INBIOGEN CO., Ltd.’s price range in the past 12 months?

INBIOGEN CO., Ltd. lowest stock price was ₩4805.00 and its highest was ₩14300.00 in the past 12 months.

What is INBIOGEN CO., Ltd.’s market cap?

INBIOGEN CO., Ltd.’s market cap is ₩51.92B.

When is INBIOGEN CO., Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were INBIOGEN CO., Ltd.’s earnings last quarter?

INBIOGEN CO., Ltd. released its earnings results on May 15, 2026. The company reported -₩1470.051 earnings per share for the quarter, missing the consensus estimate of N/A by -₩1470.051.

Is INBIOGEN CO., Ltd. overvalued?

According to Wall Street analysts INBIOGEN CO., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does INBIOGEN CO., Ltd. pay dividends?

INBIOGEN CO., Ltd. does not currently pay dividends.

What is INBIOGEN CO., Ltd.’s EPS estimate?

INBIOGEN CO., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does INBIOGEN CO., Ltd. have?

INBIOGEN CO., Ltd. has 10,044,217 shares outstanding.

What happened to INBIOGEN CO., Ltd.’s price movement after its last earnings report?

INBIOGEN CO., Ltd. reported an EPS of -₩1470.051 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.463%.

Which hedge fund is a major shareholder of INBIOGEN CO., Ltd.?

Currently, no hedge funds are holding shares in KR:101140

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

INBIOGEN CO., Ltd.

Headquartered in Pyeongtaek, South Korea, INBIOGEN Co., Ltd. is a footwear manufacturer and distributor founded in 1949. The company produces and sells shoes for children, youth, and adults, serving both the South Korean domestic market and international customers. Its extensive range of products is marketed under several popular brand names, including ARTIS, SPECS, WANGJA, NEOSPEC, and CHAMPION. INBIOGEN Co., Ltd. was formerly known as BTONE CO.,Ltd.